Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

684 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Sekine A, Hidaka S, Moriyama T, Shikida Y, Shimazu K, Ishikawa E, Uchiyama K, Kataoka H, Kawano H, Kurashige M, Sato M, Suwabe T, Nakatani S, Otsuka T, Kai H, Katayama K, Makabe S, Manabe S, Shimabukuro W, Nakanishi K, Nishio S, Hattanda F, Hanaoka K, Miura K, Hayashi H, Hoshino J, Tsuchiya K, Mochizuki T, Horie S, Narita I, Muto S. Sekine A, et al. Among authors: kai h. J Clin Med. 2022 Nov 3;11(21):6528. doi: 10.3390/jcm11216528. J Clin Med. 2022. PMID: 36362756 Free PMC article. Review.
A nationwide prospective cohort study of patients with advanced chronic kidney disease in Japan: The Reach-J CKD cohort study.
Hoshino J, Nagai K, Kai H, Saito C, Ito Y, Asahi K, Kondo M, Iseki K, Iseki C, Okada H, Kashihara N, Narita I, Wada T, Combe C, Pisoni RL, Robinson BM, Yamagata K. Hoshino J, et al. Among authors: kai h. Clin Exp Nephrol. 2018 Apr;22(2):309-317. doi: 10.1007/s10157-017-1453-2. Epub 2017 Jul 24. Clin Exp Nephrol. 2018. PMID: 28741051
Comparison of annual eGFR decline among primary kidney diseases in patients with CKD G3b-5: results from a REACH-J CKD cohort study.
Hoshino J, Tsunoda R, Nagai K, Kai H, Saito C, Ito Y, Asahi K, Kondo M, Iseki K, Iseki C, Okada H, Kashihara N, Narita I, Wada T, Combe C, Pisoni RL, Robinson BM, Yamagata K. Hoshino J, et al. Among authors: kai h. Clin Exp Nephrol. 2021 Aug;25(8):902-910. doi: 10.1007/s10157-021-02059-y. Epub 2021 Apr 21. Clin Exp Nephrol. 2021. PMID: 33881641
A digest from evidence-based Clinical Practice Guideline for Polycystic Kidney Disease 2020.
Nishio S, Tsuchiya K, Nakatani S, Muto S, Mochizuki T, Kawano H, Hanaoka K, Hidaka S, Ichikawa D, Ishikawa E, Uchiyama K, Koshi-Ito E, Hayashi H, Makabe S, Ogata S, Mitobe M, Sekine A, Suwabe T, Kataoka H, Kai H, Kaneko Y, Kurashige M, Seta K, Shimazu K, Hama T, Miura K, Nakanishi K, Horie S, Furuichi K, Okada H, Narita I; Committee of Clinical Practical Guideline for Polycystic Kidney Disease 2020. Nishio S, et al. Among authors: kai h. Clin Exp Nephrol. 2021 Dec;25(12):1292-1302. doi: 10.1007/s10157-021-02097-6. Epub 2021 Sep 26. Clin Exp Nephrol. 2021. PMID: 34564792 No abstract available.
Behaviour modification intervention for patients with chronic kidney disease could provide a mid- to long-term reduction in public health care expenditure: budget impact analysis.
Okubo R, Kondo M, Hoshi SL, Kai H, Saito C, Iseki K, Iseki C, Watanabe T, Narita I, Matsuo S, Makino H, Hishida A, Yamagata K. Okubo R, et al. Among authors: kai h. Clin Exp Nephrol. 2022 Jun;26(6):601-611. doi: 10.1007/s10157-022-02185-1. Epub 2022 Jan 27. Clin Exp Nephrol. 2022. PMID: 35084644
Long-term effectiveness of a primary care practice facilitation program for chronic kidney disease management: an extended follow-up of a cluster-randomized FROM-J study.
Imasawa T, Saito C, Kai H, Iseki K, Kazama JJ, Shibagaki Y, Sugiyama H, Nagata D, Narita I, Nishino T, Hasegawa H, Honda H, Maruyama S, Miyazaki M, Mukoyama M, Yasuda H, Wada T, Ishikawa Y, Tsunoda R, Nagai K, Okubo R, Kondo M, Hoshino J, Yamagata K. Imasawa T, et al. Among authors: kai h. Nephrol Dial Transplant. 2023 Jan 23;38(1):158-166. doi: 10.1093/ndt/gfac041. Nephrol Dial Transplant. 2023. PMID: 35195257 Clinical Trial.
Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease.
Kataoka H, Shimada Y, Kimura T, Nishio S, Nakatani S, Mochizuki T, Tsuchiya K, Hoshino J, Hattanda F, Kawano H, Hanaoka K, Hidaka S, Ichikawa D, Ishikawa E, Uchiyama K, Hayashi H, Makabe S, Manabe S, Mitobe M, Sekine A, Suwabe T, Kai H, Kurashige M, Seta K, Shimazu K, Moriyama T, Sato M, Otsuka T, Katayama K, Shimabukuro W, Fujimaru T, Miura K, Nakanishi K, Horie S, Furuichi K, Okada H, Narita I, Muto S. Kataoka H, et al. Among authors: kai h. Clin Exp Nephrol. 2023 Oct;27(10):809-818. doi: 10.1007/s10157-023-02372-8. Epub 2023 Jun 27. Clin Exp Nephrol. 2023. PMID: 37368094
684 results